Stay updated on Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.

Latest updates to the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page
- Check4 days agoChange DetectedThe clinical trial record for the derazantinib study appears unchanged.SummaryDifference0.1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov page now displays the completed Phase II derazantinib study record for advanced intrahepatic cholangiocarcinoma, with study details, results measures, participant criteria, and research locations.SummaryDifference75%

- Check18 days agoChange DetectedThe site footer revision label changes from v3.7.2 to v3.8.0, while the study page continues to show a 403 Forbidden response.SummaryDifference0.2%

- Check25 days agoChange DetectedA banner announces NIH website transition updates and says federal agencies are adopting the term “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2. The page otherwise continues to display a 403 error instead of the study record.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision number advanced from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Derazantinib in Advanced Cholangiocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Derazantinib in Advanced Cholangiocarcinoma Clinical Trial page.